Skip to content
← Back to this collection

PUBLICATIONS · 26324362

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Nov 10
First author
Schmoll HJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Schmoll HJ
      type
      Author
    2. name
      Tabernero J
      type
      Author
    3. name
      Maroun J
      type
      Author
    4. name
      de Braud F
      type
      Author
    5. name
      Price T
      type
      Author
    6. name
      Van Cutsem E
      type
      Author
    7. name
      Hill M
      type
      Author
    8. name
      Hoersch S
      type
      Author
    9. name
      Rittweger K
      type
      Author
    10. name
      Haller DG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Schmoll HJ
      type
      Author
    2. name
      Tabernero J
      type
      Author
    3. name
      Maroun J
      type
      Author
    4. name
      de Braud F
      type
      Author
    5. name
      Price T
      type
      Author
    6. name
      Van Cutsem E
      type
      Author
    7. name
      Hill M
      type
      Author
    8. name
      Hoersch S
      type
      Author
    9. name
      Rittweger K
      type
      Author
    10. name
      Haller DG
      type
      Author
    bibliography ids
    1. nci-bib-b4fb5015eab60b75fc931103
    book metadata
    content sha256
    eba8fb5d89e459345260e21120c0dd2a825965238ddd1b340950db81222bfd81
    document type
    citation
    dois
    1. 10.1200/JCO.2015.60.9107
    electronic publication date
    display
    2015 Aug 31
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26324362
    immutable id
    pubmed:26324362@eba8fb5d89e459345260e21120c0dd2a825965238ddd1b340950db81222bfd81
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    32
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3733-40
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26324362
      provenance
      batch id
      4c1ece5bfc3d8e2be622
      provider
      NCBI PubMed ESummary
      record sha256
      012d0082c6f9aff5c41604e85b8c951e22a90feed3545733cc7d369c85713f46
      response sha256
      85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
      retrieved at
      2026-09-09T23:47:12.730551+00:00
      publication date
      display
      2015 Nov 10
      precision
      day
      year
      2015
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26324362/
      title
      Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

      Preserved source evidence · Not medical advice